AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration
Collaboration expanded from five to seven targets and provides AbCellera the option to co-develop therapeutic programs in partnership with Empirico VANCOUVER, BC & SAN DIEGO– AbCellera (Nasdaq: ABCL) and Empirico… Read More



